About this article Cite this article Hydes, T.J., Burton, R., Inskip, H
The WHO FCTC is a milestone in the promotion of public health
E-cigarettes a tool to reduce inequalities in smoking
He can remember them and reach toward them, but he cannot make the crossing on their behalf
The HDL-Atherosclerosis Treatment Study (HATS), a three-year randomized controlled trial in 160 patients with documented CHD and low HDL concentrations, found that a combination of simvastatin and nicotinic acid (2-3 g/day) increased HDL concentrations, inhibited the progression of coronary artery stenosis (narrowing), and decreased the frequency of cardiovascular events, including myocardial infarction and stroke, compared to placebo (88)
The use of e-cigarettes (vapes, EC) is often promoted as a helpful tool for quitting conventional cigarette (CC) smoking